Breakthrough Drug Status for Roche and AstraZeneca

19.02.2016 - Major drug makers Roche and AstraZeneca have been granted breakthrough therapy designations (BTD) by the US Food and Drug Administration (FDA) for treatments in multiple sclerosis...